EVARUCABGENE AUTOLEUCEL
UNII 2276KMR6L5

Substance Identification & Data

This profile provides standardized clinical and technical data for Evarucabgene Autoleucel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2276KMR6L5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
2276KMR6L5
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
EVARUCABGENE AUTOLEUCEL
Official standardized name for this substance within the FDA UNII nomenclature system.
USAN ID
NO-253
Identifier assigned by the United States Adopted Names Council.
Substance Type
Evarucabgene Autoleucel
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Evarucabgene Autoleucel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Evarucabgene Autoleucel

Common Names & Synonyms

EVARUCABGENE AUTOLEUCEL [USAN]
NXC-201, is defined as autologous T cells transduced ex-vivo with anti-BCMA CAR retroviral vector, encoding the CAR targeted to human BCMA, suspended in saline for injection with 2.5% human albumin.

Technical Codes

NXC-201

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record